In August, Rumah Sakit Pusat Pertahanan Negara Panglima Besar Soedirman (RSPPN), Indonesia’s National Defense Central Hospital, officially signed a strategic cooperation agreement with the Yangtze River Delta TCM Industry Delegation. The two parties will establish a long-term collaboration mechanism covering clinical application of Traditional Chinese Medicine (TCM), academic exchanges, talent training and compliant conversion of TCM herbal products, to advance the orderly localized development of TCM systems in Indonesia.

RSPPN is a large national tertiary general hospital in Indonesia and the country’s largest military hospital. It boasts sound clinical platforms, teaching systems and local medical resources, and carries strong demonstration and promotion value within Indonesia’s healthcare system. Building on the policy framework for China-Indonesia cooperation in traditional medicine, this signing leverages the strengths of the Yangtze River Delta in TCM research, clinical practice and industrial resources, and forms a cooperation pathway for introducing TCM techniques, characteristic therapies and herbal preparations into Indonesia.

Pursuant to the agreement, the two sides will carry out multi-dimensional practical cooperation: jointly build a demonstration clinic featuring TCM services to explore the clinical application of acupuncture, rehabilitation physiotherapy, chronic disease conditioning and other signature TCM therapies in Indonesia; jointly organize TCM academic seminars and exchange training for medical staff, to cultivate interdisciplinary medical professionals proficient in both Indonesian regulations and TCM theories; push forward local registration and evidence-based research of TCM herbal products and TCM medical devices in compliance with Indonesia’s regulatory requirements for traditional medicine, promote complementary integration between TCM and Indonesia’s indigenous traditional medicine (Jamu), and develop health solutions tailored to local people’s needs.

This signing marks an important practice for TCM to further explore the Southeast Asian market under the Belt and Road Initiative. As a leading medical institution in Indonesia, RSPPN provides an authoritative platform for the clinical validation and reputation building of TCM. The Yangtze River Delta partners deliver mature TCM technologies, standards and industrial resources, enabling complementary strengths and mutual empowerment.

As the coordinating facilitator of this cooperation, Sunrise continues to build a bridge connecting the Chinese and Indonesian medical industries. It provides one-stop support for the TCM project, including AKL/CDAKB registration consultation, local compliance implementation and supply chain matching. Going forward, all parties will steadily push forward project delivery, continuously provide safe and effective TCM health services, facilitate the diversified development of traditional medicine in Indonesia, and bring benefits to local residents.